IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $253,483 | +12.0% | 6,178 | +3.1% | 0.04% | -28.8% |
Q4 2022 | $226,242 | -3.3% | 5,990 | +13.2% | 0.06% | +25.5% |
Q3 2022 | $234,000 | +15.8% | 5,290 | -3.1% | 0.05% | -42.0% |
Q2 2022 | $202,000 | -65.5% | 5,457 | -65.5% | 0.08% | +3.8% |
Q1 2022 | $585,000 | -42.9% | 15,796 | -26.9% | 0.08% | -64.9% |
Q3 2020 | $1,025,000 | +8.2% | 21,600 | +85.1% | 0.22% | +344.0% |
Q1 2019 | $947,000 | – | 11,670 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |